Nasal Sprays Global Market Report 2025

The nasal sprays market size has grown rapidly in recent years. It will grow from $30.36 billion in 2024 to $33.63 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. Growth during the historical period was driven by rising levels of environmental pollution, increased use of vaccines and pain management delivery, wider adoption in pediatric care, growing healthcare spending in emerging markets, and a higher prevalence of seasonal allergies.

The nasal sprays market size is expected to see rapid growth in the next few years. It will grow to $50.19 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. Growth in the forecast period will be fueled by the rising incidence of respiratory conditions, an aging population, greater awareness of non-invasive drug delivery options, increased demand for over-the-counter (OTC) medications, and ongoing product innovations and formulation advancements. Key trends expected during this period include progress in nasal spray delivery technologies, the integration of digital health tools, advances in drug formulation science, enhanced systemic drug delivery through the nasal route, and the adoption of preservative-free formulations.

The rising prevalence of respiratory disorders is expected to drive the growth of the nasal sprays market. Respiratory disorders are medical conditions that affect normal lung function and the breathing process. An increase in smoking rates contributes to these disorders by damaging lung tissue and reducing respiratory efficiency. Nasal sprays assist in managing respiratory conditions by delivering medication directly to the nasal passages, helping to reduce inflammation, clear congestion, and improve airflow. For example, in November 2023, the Bureau of Labor Statistics, a US-based government agency, reported that in 2022, the illness rate among private industry employers increased to 45.2 cases per 10,000 full-time equivalent (FTE) workers, up from 37.7 cases in 2021. This rise was mainly attributed to an increase in respiratory illnesses, which rose from 27.8 cases per 10,000 FTE workers in 2021 to 35.8 cases in 2022. Thus, the growing incidence of respiratory disorders is fueling the demand for nasal sprays.

Leading companies in the nasal sprays market are prioritizing technological advancements, including the development of next-generation nasal sprays, to enhance drug delivery, increase bioavailability, and improve patient compliance. These advanced nasal sprays are formulated and designed to deliver precise doses, promote better absorption, offer quicker relief, and ensure a more comfortable user experience compared to traditional options. For instance, in October 2023, Haleon Plc, a UK-based pharmaceutical company, introduced Otrivin Nasal Mist - a next-generation nasal spray designed for individuals with nasal congestion due to colds, allergies, or sinusitis. It provides fast and effective relief by narrowing swollen blood vessels in the nasal passages, enabling easier breathing within minutes and lasting up to 12 hours. Its gentle microdroplet mist and ergonomic design offer comfortable use without causing irritation or dripping.

In January 2024, Kindeva Drug Delivery L.P., a US-based manufacturing firm, acquired Summit Biosciences Inc. for an undisclosed amount. This acquisition is intended to expand Kindeva’s pharmaceutical capabilities and strengthen its global leadership in drug delivery by incorporating specialized nasal spray drug development and manufacturing expertise. Summit Biosciences Inc. is a US-based pharmaceutical company specializing in the development, production, and commercialization of both generic and innovative nasal spray medicines.

Major players in the nasal sprays market are Pfizer Inc., Johnson & Johnson Services, Merck & Co. Inc., Bayer AG, AstraZeneca plc., Novartis AG, GlazoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Catalent Inc., AptarGroup, Cipla Ltd, Emergent, Assertio Therapeutics Inc., Aytu BioPharma Inc., Leeford Healthcare Ltd, Ultratech India Limited, Aishwarya Group, Aurena Laboratories, Innovus Pharmaceuticals Inc.

North America was the largest region in the nasal sprays market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nasal spray report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nasal sprays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Nasal sprays are liquid medications administered through the nostrils using a spray device. They offer targeted relief for conditions such as nasal congestion, allergies, and sinus infections. These sprays function by delivering the medication directly into the nasal passages, resulting in a quicker onset of action. Their popularity stems from their ease of use and rapid effectiveness.

Nasal spray products include steroid nasal sprays, antihistamine nasal sprays, decongestant nasal sprays, saline nasal sprays, and other varieties. Steroid nasal sprays contain corticosteroids that help reduce inflammation in the nasal passages and are available both over-the-counter and by prescription. The distribution channels for these products include retail pharmacies, hospital pharmacies, and online pharmacies. Applications for nasal sprays span across nasal congestion, allergic and non-allergic rhinitis, central nervous system disorders, vaccinations, and other uses. End-users encompass home care settings, hospitals, clinics, and community healthcare facilities.

The nasal sprays market research report is one of a series of new reports that provides nasal sprays market statistics, including the nasal sprays industry's global market size, regional shares, competitors with the nasal sprays market share, detailed nasal sprays market segments, market trends and opportunities, and any further data you may need to thrive in the nasal sprays market. This nasal spray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nasal sprays market consists of sales of decongestants, antihistamines, and corticosteroids. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.